Live news related to NANOBIOTIX stock (FR0011341205): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
The French biotech has seen a dramatic increase over the past five sessions, driven by clinical and financial catalysts.
The French biotech takes a breather this Tuesday after a spectacular rise of over 400% in three months.
The French biotech company takes a breather after an exceptional week that saw it surge over 33% in seven days.
The French biotech company closed the trading session on Friday, October 10, at 22.40 euros, down 6.28% from the previous day. This decline follows a …
The French biotech is among the top gainers on the Paris stock exchange at the start of the session, driven by a spectacular momentum that has been bu…
